Stay updated with breaking news from Updated Incidence. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Positive Review from the Drug Safety Monitoring Board (DSMB) on the Ongoing Phase 2 Clinical Trial in Ulcerative Colitis. Positive Opinion for Orphan Drug Designation from the European Medicines Agency in the
OSE Immunotherapeutics Updates on Anti-IL-7 Receptor Antagonist OSE-127/S95011, a Breakthrough Approach in Chronic Inflammatory Autoimmune Diseases and Hematology· Positive Phase 1 clinical results published in 'The Journal of Immunology’ (online)· &...
Positive Phase 1 clinical results published in 'The Journal of Immunology' (online) Two ongoing Phase 2 clinical trials in Ulcerative Colitis and primary Sjögren's Syndrome Positive